Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer (BOND)

This study has been terminated.
(Change in study design)
Sponsor:
Information provided by (Responsible Party):
Cold Genesys, Inc.
ClinicalTrials.gov Identifier:
NCT01438112
First received: September 19, 2011
Last updated: July 27, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: June 2019
  Estimated Primary Completion Date: November 2018 (Final data collection date for primary outcome measure)